Exelixis
Price & Volume
Stats
See moreOpen | $34.70 |
Previous Close | $34.65 |
Day Range | $34.41-$34.99 |
52W Range | $19.20-$36.60 |
Market Cap | $9.8B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $2B |
Revenue Growth (YoY) | 14.3% |
Gross Profit (12 Mos) | $1.5B |
Diluted EPS | $1.55 |
News
See moreYahoo Finance • 2 months ago
Exelixis Announces Final Results from Phase 3 Pivotal CABINET Study Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2024 and Published in New England Journal of Medicine
Yahoo Finance • 3 months ago
Is Caligan Partners Bullish on Exelixis Inc (EXEL) Right Now?
Yahoo Finance • 8 months ago
30 Biggest Biotechnology Companies in the World
Yahoo Finance • 9 months ago
4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
About
CEO | Dr. Michael M. Morrissey Ph.D. |
CFO | Mr. Christopher J. Senner |
Address | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,310 |
